CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$247,000
-18.5%
102,8000.0%0.00%
Q4 2020$303,000
+93.0%
102,8000.0%0.00%
Q3 2020$157,000
-38.9%
102,8000.0%0.00%
Q2 2020$257,000
+21.2%
102,800
-1.3%
0.00%
Q1 2020$212,000
-46.5%
104,118
-18.7%
0.00%
Q4 2019$396,000
-14.3%
128,018
-7.4%
0.00%
Q3 2019$462,000
+3.4%
138,318
-0.9%
0.00%
-100.0%
Q2 2019$447,000
+11.5%
139,6000.0%0.00%
Q1 2019$401,000
-28.5%
139,6000.0%0.00%
-100.0%
Q4 2018$561,000
-38.4%
139,600
-28.4%
0.00%0.0%
Q3 2018$910,000
-19.0%
194,945
+42.8%
0.00%
-50.0%
Q2 2018$1,124,000
+97.5%
136,5180.0%0.00%
+100.0%
Q1 2018$569,000
+28.2%
136,5180.0%0.00%0.0%
Q4 2017$444,000
+83.5%
136,5180.0%0.00%
Q3 2017$242,000
+69.2%
136,5180.0%0.00%
Q2 2017$143,000
-26.3%
136,5180.0%0.00%
Q1 2017$194,000
+23.6%
136,5180.0%0.00%
Q4 2016$157,000
+3.3%
136,5180.0%0.00%
Q3 2016$152,000
-5.0%
136,5180.0%0.00%
Q2 2016$160,000
+10.3%
136,5180.0%0.00%
Q1 2016$145,000
+10.7%
136,5180.0%0.00%
Q4 2015$131,000
-10.3%
136,5180.0%0.00%
Q3 2015$146,000
-40.2%
136,5180.0%0.00%
Q2 2015$244,000
+6.6%
136,5180.0%0.00%
Q1 2015$229,0000.0%136,5180.0%0.00%
Q4 2014$229,000
-6.1%
136,5180.0%0.00%
Q3 2014$244,000136,5180.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders